Ticker Symbol: AVDL
Avadel Pharmaceuticals plc - ADR
$10.39 - 20-12-2024 4 p.m. ET
Exchange: NASDAQ
Country:
Ireland
Currency:
USD
Asset
Type: ADR
CIK:0001012477
Company Profile
avadel pharmaceuticals plc (nasdaq: avdl) is a specialty pharmaceutical company that seeks to develop differentiated pharmaceutical products that are safe, effective and easy to take, helping patients adhere to their prescribed medical treatment and see better results. avadel’s current portfolio of products and product candidates focuses on the urology, central nervous system (cns) / sleep, and hospital markets. the company is headquartered in dublin, ireland with operations in st. louis, missouri and lyon, france.
Sector: Manufacturing
Industry: Medicinal and Botanical Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: Block 10-1 Blanchardstown Corporate Park
Website: https://www.avadel.com/
CEO: Gregory Divis
Tags:
- Health Technology
- Medical Specialties
- Manufacturing
- Medicinal and Botanical Manufacturing
Pricing
Last Updated: October 20, 2023 03:00 PM EST
Previous Close: $10.33
Change:
$0.06
(
0.58%)
Days Range: $10.19 - $10.68
Beta: 1.20
52wk. High: $16.85
52wk. Low: $5.33
Ytd. Change 44.86%
50 Day Moving Average: $11.43
200 Day Moving Average: $12.97
Shares Outstanding: 89367975
Valuation
Market Cap: 92.3B
PE Ratio: -
EPS (TTM): 0
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A